Navigation Links
UAB's Lisa Guay-Woodford earns top international nephrology prize
Date:3/12/2009

ical applications. The grant, one of the largest single grants from the National Institutes of Health in UAB history, established the Center for Clinical and Translational Sciences at UAB, of which Guay-Woodford is the director.

At the national level, Guay-Woodford has served as president of the Society for Pediatric Research, a councilor to the International Pediatric Nephrology Association, and a member of Scientific Advisory Committees for the Polycystic Kidney Research Foundation, the Burroughs Wellcome Fund, and the National Institutes of Health. She also is a member of the American Society of Nephrology, American Society of Pediatric Nephrology, International Pediatric Nephrology Association, Society for Pediatric Research and American Pediatric Society.

Guay-Woodford graduated from the College of the Holy Cross summa cum laude and earned her M.D. degree from Harvard Medical School. She then completed pediatric training and a pediatric nephrology fellowship at Boston Children's Hospital.

Guay-Woodford is one of three recipients of the Lillian Jean Kaplan International Prize for Advancement in the Understanding of Polycystic Kidney Disease for 2009. The others are Dr. Friedhelm Hildebrandt from the University of Michigan and Dr. Corinne Antignac from Necker Hospital in Paris, France. The three will receive their award and $50,000 each at the World Congress of Nephrology May 25 in Milan, Italy.

"For the first time ever, the 2009 Lillian Jean Kaplan International Prize for Advancement in the Understanding of Polycystic Kidney Disease honors three (not two) world renowned kidney doctors - all of whom are pediatric nephrologists," said Dan Larson, PKD Foundation President and CEO. "The significance of the first testifies to Mr. Kaplan's incredible generosity, especially during a major recession, and the second - because all three passionately strive to save the most vulnerable, fragile and precious of the world's PKD patients."'/>"/>

Contact: Jennifer Lollar
jpark@uab.edu
205-934-3888
University of Alabama at Birmingham
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. First fuel-handling facility in the Galapagos earns environmental certification
2. Goulbourne earns NSF award to research heart stent sensors
3. SC Magazine: Entrust Entelligence Messaging Server Earns Five-Stars and Recommended Rating
4. Simplifying manufacture of drugs, plastics earns UH chemist top honor
5. Computer learns dogspeak
6. UT researcher earns $1.3M grant to study toxic cleanup at DOD sites
7. Oxford Journals and the International Society for Computational Biology announce new partnership
8. Food counterfeiting, contamination outpace international regulatory systems
9. 150 years of Darwins landmark book spawns international conference
10. International study identifies gene variants associated with early heart attack
11. Internationally acclaimed researcher joins UH faculty thanks to $5.5 million grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2015)...   MedNet Solutions , a global life ... systems, has recently bolstered its iMedNet™ ... iMedNet as the eClinical solution of ... consultants.  Building on the Program,s existing benefits (including ... co-marketing opportunities), MedNet,s new and improved program provides ...
(Date:2/10/2015)...  Alere Inc. (NYSE: ALR), a global leader ... the quarter ended December 31, 2014. ... Alere said, "We made substantial progress in the ... leader in rapid diagnostics and delivering against our ... in early January enabled us to substantially reduce ...
(Date:2/5/2015)... PARK, N.C. , Feb. 5, 2015  Marken ... specialist logistics company and has launched a new marketing ... Clinical Logistics Organization (CLO).  The new campaign focuses on ... on patient, protocol and shipments. The first ... , aligns Marken,s priorities with its client,s priorities. ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35
... This press release is available in Spanish . ... brown marmorated stink bug (BMSB) is now in at least 39 ... major economic threat to orchard fruits, garden vegetables and row crops. ... pest as its top "invasive insect of interest." But ...
... Irvine, Calif., Jan. 7, 2013 Halting climate change will ... system" to eradicate harmful carbon dioxide emissions, not just stabilize ... scientists. In a Jan. 9 paper in Environmental ... and others take a fresh look at the popular "wedge" ...
... immigrants from Italy and their offspring form one of the ... on their state of health and risk of mortality. In ... the University of Zurich,s Institute of Social and Preventative Medicine ... background. Immigrants from Italy live longer ...
Cached Biology News:Combating USDA's top-ranked invasive insect 2Major cuts to surging CO2 emissions are needed now, not down the road, study finds 2Italian immigrants live longer 2
(Date:2/27/2015)... 2015 A paper published today, " ... " in Science Translational Medicine, demonstrates ... reduce the risk associated with investing in the ... levels of funding for developing so-called "orphan" drugs. ... collaboration between scientists at the National Center for ...
(Date:2/27/2015)... SAN DIEGO , Feb. 27, 2015  Pfenex ... in the development of biosimilar therapeutics, today announced that ... San Francisco Marriott Marquis on March 2 nd ... will participate on a panel discussing the current state ... World of Biosimilars . For more ...
(Date:2/26/2015)... NEW YORK , Feb. 26, 2015 ... commenced Factual Stock Report coverage on MabVax Therapeutics ... Inc. (MBVX) is a clinical stage biotechnology company focused ... address unmet medical needs in the treatment of cancer. ... products based on the protective immune responses generated by ...
(Date:2/26/2015)... , Feb. 26, 2015   Regulus Therapeutics Inc ... leading the discovery and development of innovative medicines targeting ... Ph.D., President and Chief Executive Officer of Regulus, will ... 35 th Annual Healthcare Conference on Wednesday, March ... being held at the Boston Marriott Copley Place.  ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3
... EVANSTON, Ill. --- Carbon nanotubes are promising materials ... mechanical, thermal, chemical, optical and electrical properties. , ... nanotubes to make thin films that are semitransparent, ... of colors, with an appearance similar to stained ...
... April 9 Baxter Healthcare Corporation,today announced ... coating, the first needleless intravenous (IV) connector ... for hospitals in the,United States and Canada. ... kill on,average 99.9 percent or more of ...
... discussed during Omnicell,educational, programs April 15 at ... The Mid-America Club in Chicago, MOUNTAIN ... Inc. (Nasdaq: OMCL ), a leading provider,of ... in,healthcare facilities, and Rice Memorial Hospital today announced ...
Cached Biology Technology:Carbon nanotubes made into conductive, flexible 'stained glass' 2Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals 2Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals 3Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals 4Rice Memorial Hospital Implements SinglePointe(TM) Automated Patient-Specific Management Solution From Omnicell 2Rice Memorial Hospital Implements SinglePointe(TM) Automated Patient-Specific Management Solution From Omnicell 3
... PBL's bioassays for interferons are cytopathic effect inhibition ... Sample types include; tissue culture supernatents; serum ... these assays, one unit is defined as the ... the cytopathic effect of viral infection by 50%. ...
Request Info...
...
... is >95%\nNEN Radiolabeled Ligands\n\nReceptor-related research has long ... new radiolabeled ligands selected to keep pace ... range of products and services for receptor ... state-of-the-art radioligands. If you do not find ...
Biology Products: